Andrei Brateanu, MD
Specialty in Diseases & Conditions
- Asthma
- Atrial Fibrillation
- Coronary Artery Disease
- Diabetes
- Hypertension and Diabetes
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Andrei Brateanu, MD
Andrei Brateanu, MD, FACP, is the Senior Associate Program Director of the Internal Medicine Residency Program in the Medicine Institute of Cleveland Clinic and Assistant Professor of Medicine at Case Western Reserve University. He practices general internal medicine and directs the Cleveland Clinic Internal Medicine Residency Program Evaluation Committee. His research focus is in the area of clinical education, with particular interest in emerging strategies to improve residents’ teaching and evaluation. Over the course of his academic career, he was the principal investigator of several research grants, co-authored numerous peer-reviewed articles, three book chapters and co-edited two books. On multiple occasions, he chaired sessions at national and regional professional meetings and led workshops aimed at resident education and competency assessment. He is currently a member of three Medicine Institute committees and two Cleveland Clinic research awards committees, including the William E. Lower Award.
Dr. Brateanu received his medical degree from Iasi Medical University, Romania and completed a postdoctoral fellowship with the Center for Value, Quality and Effectiveness Research at the Cleveland Clinic.
Education & Professional Highlights
Appointed
2011
Education & Fellowships
Residency - Huron Hospital
Internal Medicine
Cleveland,
OH
1999
Medical Education - GR. T. Popa University of Medicine & Pharmacy
Iasi,
1990
Certifications
- Internal Medicine
Research & Publications
See publications for Andrei Brateanu, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 10/24/2024, Dr. Brateanu has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
